Treatment of staphylococcal infection

British Medical Journal

Volumn 330, Issue 7498, 2005, Pages 976-977

  Amyes, Sebastian G B ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; LINEZOLID; OXOLINIDONES; QUINOLONE DERIVATIVE; STREPTOGRAMIN DERIVATIVE; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG; VANCOMYCIN;

ALLERGY; BACTERIAL GROWTH; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; BONE INFECTION; DRUG USE; EDITORIAL; ENDOCARDITIS; FOOD AND DRUG ADMINISTRATION; HOME CARE; HOSPITAL CARE; HUMAN; INFECTIOUS ARTHRITIS; PENICILLIN RESISTANCE; PRESCRIPTION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UNITED KINGDOM; GENETICS; PHARMACEUTICS;

HUMANS; METHICILLIN RESISTANCE; PRESCRIPTIONS, DRUG; STAPHYLOCOCCAL INFECTIONS; TECHNOLOGY, PHARMACEUTICAL;

EID: 18044396556     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.330.7498.976     Document Type: Editorial

References (10)

1. Tiemersma EW, Bronzwaer SLAM, Lyyukäinen O, Degener JE, Schrijnemakers P, Bruinsma N, et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004;10:1627-34.
2. Fitzgerald JR, Musser JM. Evolutionary genomics of pathogenic bacteria. Trends Microbiol 2001;9:547-53.
3. Courvalin P. The Garrod lecture. Evasion of antibiotic action by bacteria. J Antimicrob Chemother 1996;37:855-69.
4. Morris A, Kellner JD, Low DE. The superbugs: evolution, dissemination and fitness. Curr Opin Microbiol 1998;1:524-9.
5. Phillips I, Casewell M, Cox T, De Groot B, Friis C, Jones R, et al. Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. J Antimicrob Chemother 2004;53:28-52.
6. Howe RA, Monk A, Wootton M, Walsh TR, Enright MC. Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages. Emerg Infect Dis 2004;10:855-7.
7. Howe RA, Monk A, Wootton M, Walsh TR, Enright MC. Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages. Emerg Infect Dis 2004;10:855-7.
8. Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, Flannagan SE, et al. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 2003;302:1569-71.
9. Veterans Health Administration Pharmacy Benefits Management Strategic Healthcare Group and the Medical Advisory Panel. Criteria for use of linezolid (Zyvox™), quinupristin-dalfopristin (Synercid®), and daptomycin (Cubicin™). www.vapbm.org/criteria/linezolidcriterial.pdf (accessed 14 Feb 2005).
10. Vandenbroucke-Grauls CMJ. Methicillin-resistant Staphylococcus aureus control in hospitals: the Dutch experience. Infect Control Hosp Epidemiol 1996;17:512-3.